Mediator modulation therapy of severe sepsis and septic shock: Does it work?

被引：33

作者：

Dellinger, RP ^{[1
]}

Parrillo, JE

机构：

[1] Univ Med & Dent New Jersey, Robert Wood Johnson Med Sch, Cooper Hosp, Dept Med,Sect Crit Care Med, Camden, NJ 08103 USA

[2] Univ Med & Dent New Jersey, Robert Wood Johnson Med Sch, Cooper Hosp,Cooper Heart Inst, Dept Med,Div Cardiovasc Dis & Crit Care Med, Camden, NJ 08103 USA

来源：

CRITICAL CARE MEDICINE | 2004年 / 32卷 / 01期

关键词：

D O I：

10.1097/01.CCM.0000105423.06091.8E

中图分类号：

R4 [临床医学];

学科分类号：

1002 ; 100602 ;

摘要：

引用

页码：282 / 286

页数：5

共 50 条

[1] EFFICACY AND SAFETY OF MONOCLONAL-ANTIBODY TO HUMAN TUMOR-NECROSIS-FACTOR-ALPHA IN PATIENTS WITH SEPSIS SYNDROME - A RANDOMIZED, CONTROLLED, DOUBLE-BLIND, MULTICENTER CLINICAL-TRIAL [J].

ABRAHAM, E ;

WUNDERINK, R ;

SILVERMAN, H ;

PERL, TM ;

NASRAWAY, S ;

LEVY, H ;

BONE, R ;

WENZEL, RP ;

BALK, R ;

ALLRED, R ;

PENNINGTON, JE ;

WHERRY, JC .

JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1995, 273 (12) :934-941

[2] Efficacy and safety of tifacogin (recombinant tissue factor pathway inhibitor) in severe sepsis -: A randomized controlled trial [J].

Abraham, E ;

Reinhart, K ;

Opal, S ;

Demeyer, I ;

Doig, C ;

Rodriguez, AL ;

Beale, R ;

Svoboda, P ;

Laterre, PF ;

Simon, S ;

Light, B ;

Spapen, H ;

Stone, J ;

Seibert, A ;

Peckelsen, C ;

De Deyne, C ;

Postier, R ;

Pettilä, V ;

Sprung, CL ;

Artigas, A ;

Percell, SR ;

Shu, V ;

Zwingelstein, C ;

Tobias, J ;

Poole, L ;

Stolzenbach, JC ;

Creasey, AA .

JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2003, 290 (02) :238-247

[3] p55 tumor necrosis factor receptor fusion protein in the treatment of patients with severe sepsis and septic shock - A randomized controlled multicenter trial [J].

Abraham, E ;

Glauser, MP ;

Butler, T ;

Garbino, J ;

Gelmont, D ;

Laterre, PF ;

Kudsk, K ;

Bruining, HA ;

Otto, C ;

Tobin, E ;

Zwingelstein, C ;

Lesslauer, W ;

Leighton, A .

JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1997, 277 (19) :1531-1538

[4] Lenercept (p55 tumor necrosis factor receptor fusion protein) in severe sepsis and early septic shock: A randomized, double-blind, placebo-controlled, multicenter phase III trial with 1,342 patients [J].

Abraham, E ;

Laterre, PF ;

Garbino, J ;

Pingleton, S ;

Butler, T ;

Dugernier, T ;

Margolis, B ;

Kudsk, K ;

Zimmerli, W ;

Anderson, P ;

Reynaert, M ;

Lew, D ;

Lesslauer, W ;

Passe, S ;

Cooper, P ;

Burdeska, A ;

Modi, M ;

Leighton, A ;

Salgo, M ;

Van der Auwera, P .

CRITICAL CARE MEDICINE, 2001, 29 (03) :503-510

[5] Multicenter evaluation of a human monoclonal antibody to Enterobacteriaceae common antigen in patients with Gram-negative sepsis [J].

Albertson, TE ;

Panacek, EA ;

MacArthur, RD ;

Johnson, SB ;

Benjamin, E ;

Matuschak, GM ;

Zaloga, G ;

Maki, D ;

Silverstein, J ;

Tobias, JK ;

Haenftling, K ;

Black, G ;

Cowens, JW .

CRITICAL CARE MEDICINE, 2003, 31 (02) :419-427

[6] Effect of treatment with low doses of hydrocortisone and fludrocortisone on mortality in patients with septic shock [J].

Annane, D ;

Sébille, V ;

Charpentier, C ;

Bollaert, PE ;

François, B ;

Korach, JM ;

Capellier, G ;

Cohen, Y ;

Azoulay, E ;

Troché, G ;

Chaumet-Riffaut, P ;

Bellissant, E .

JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2002, 288 (07) :862-871

[7] Administration of the nitric oxide synthase inhibitor NG-Methyl-L-arginine hydrochloride (546C88) by intravenous infusion for up to 72 hours can promote the resolution of shock in patients with severe sepsis:: Results of a randomized, double-blind, placebo-controlled multicenter study (study no. 144-002) [J].

Bakker, J ;

Grover, R ;

McLuckie, A ;

Holzapfel, L ;

Andersson, J ;

Lodato, R ;

Watson, D ;

Grossman, S ;

Donaldson, J ;

Takala, J .

CRITICAL CARE MEDICINE, 2004, 32 (01) :1-12

[8] The effects of ibuprofen on the physiology and survival of patients with sepsis [J].

Bernard, GR ;

Wheeler, AP ;

Russell, JA ;

Schein, R ;

Summer, WR ;

Steinberg, KP ;

Fulkerson, WJ ;

Wright, PE ;

Christman, BW ;

Dupont, WD ;

Higgins, SB ;

Swindell, BB .

NEW ENGLAND JOURNAL OF MEDICINE, 1997, 336 (13) :912-918

[9] Efficacy and safety of recombinant human activated protein C for severe sepsis. [J].

Bernard, GR ;

Vincent, JL ;

Laterre, P ;

LaRosa, SP ;

Dhainaut, JF ;

Lopez-Rodriguez, A ;

Steingrub, JS ;

Garber, GE ;

Helterbrand, JD ;

Ely, EW ;

Fisher, CJ .

NEW ENGLAND JOURNAL OF MEDICINE, 2001, 344 (10) :699-709

[10] Role of nitric oxide in inflammatory conditions [J].

Blantz, RC ;

Munger, K .

NEPHRON, 2002, 90 (04) :373-378

← 1 2 3 4 5 →